Delivery Order SPE2DR25D2212-SPE2DR26FB9HH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,919.67 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick, a pharmaceutical product, with performance in Conshohocken, Pennsylvania. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and carries an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $24,619.47 to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick, a pharmaceutical product for cardiovascular disease management. The contract, issued on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. No set-aside designation was applied to this competitive...
- The Defense Logistics Agency awarded a $7,922.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick, a prescription medication used to treat high cholesterol. The award was issued on November 28, 2025, with a completion deadline of December 1, 2025, and represents a non-competitive delivery order under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,955.33 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This competitive award, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, represents a firm fixed-price transaction with no set-aside designation. The drug will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $35,687.57 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, a pharmaceutical product used in cardiovascular disease management. The contract, awarded on October 27, 2025, with an ultimate completion date of October 28, 2025, operates under a firm fixed-price structure with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $6,610.84 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick, a pharmaceutical product for cardiovascular disease management. This competitively awarded, firm fixed-price delivery order was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,154.79 on October 21, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by October 22, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub for federal...
- The Defense Logistics Agency awarded a delivery order valued at $15,662.94 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/mL SureClick auto-injectors. This competitive, non-set-aside contract utilizes firm fixed price terms and was executed on November 13, 2025, with an ultimate completion date of November 14, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $26,872.01 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed-price, non-set-aside contract was executed on December 30, 2025, with a completion date of December 31, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,735.27 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. The award, issued on December 30, 2025, with a completion date of December 31, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. This delivery order is unset-aside and competitively sourced, consistent with AmerisourceBergen's standard federal...
- SPE2DR25D2212Indefinite Delivery Contract
- SPE2DR25D2212-SPE2DR26FB9HHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $19,952.58 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/ml SureClick, a pharmaceutical product. This non-set-aside, competitively awarded delivery order carries firm fixed pricing and is scheduled for completion by November 25, 2025. The award was issued on November 24, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen is a major pharmaceutical distributor providing comprehensive medical supplies to federal customers including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.0k | 11/23/25 |